Bartronics India Ltd. — Capital/Financing Update 2026

Feb 27, 2026

Date: 27[th] February, 2026

	To, BSE Limited, Listing Department, P.J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532694	To, National Stock exchange of India Limited, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 Symbol: ASMS

Dear Sir/Madam,

Sub: Outcome of Board Meeting held on 27[th] February, 2026

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“ SEBI LODR Regulations ”), we hereby inform that the Board of Directors of Avio Smart Market Stack Limited (formerly known as Bartronics India Limited) (“ the Company ”) at its meeting held today, i.e., Friday, February 27, 2026, has, inter alia, considered and approved the following matters:

1. Investment Terms with Huwel Lifescience Private Limited Further to the Company’s earlier intimation dated September 23, 2025, and consent of the Audit Committee, the Board has approved the revision in the investment terms with Huwel Lifesciences Private Limited. The revised terms, inter alia, provide as follows:

2. An investment of INR 15,00,00,000 (Indian Rupees Fifteen Crore only), to be infused in two tranches of INR 7,50,00,000 each;

3. Acquisition of 4.25% equity stake in Huwel Lifesciences Private Limited on a fully diluted basis (post allotment); and

4. Strategic business collaboration between the Company and Huwel Lifesciences Private Limited for the joint identification, development, and execution of projects, under which the Company shall be entitled to 40% of the Net Project Revenue derived from projects facilitated or supported by the Company or its affiliates, in accordance with the mutually agreed terms and conditions between the parties.

2. Execution of Share Subscription cum Shareholders’ Agreement

The Board has also approved the execution of a Share Subscription cum Shareholders’ Agreement (“SSSHA”) with Huwel Lifesciences Private Limited and its promoters, setting out the detailed terms and conditions governing the investment and inter se rights and obligations of the parties.

In accordance with the requirements outlined under Point 2 of Para B of Part A of Schedule III read with Regulation 30 of SEBI LODR Regulations, the requisite disclosures are provided in Annexure – A below.

The Meeting of the Board commenced at 2:30 and concluded at 3:15.

This is for your information and record.

Thanking You,

Yours Faithfully, For Avio Smart Market Stack Limited

(Formerly known as Bartronics India Limited)

Digitally signed DIKSHA OMER by DIKSHA OMER Date: 2026.02.27 15:33:03 +05'30' Diksha Omer Company Secretary

Annexure – A

Name(s) of parties with whom the agreement is entered	Huwel Lifesciences Private Limited and its promoters
Purpose of entering into the agreement	This Agreement sets out the terms governing the investment of INR 15,00,00,000 in Huwel Lifesciences Private Limited for the acquisition of a 4.25% equity stake on a fully diluted basis (post allotment). It further establishes a strategic collaboration between the parties, including the Company’s entitlement to 40% of Net Project Revenue from projects facilitated or supported by it or its affiliates.
Shareholding, if any, in the entity with whom the agreement is executed;	Upon completion of the investment of INR 15,00,00,000, the Company will hold 4.25% equity stake (post allotment, fully diluted basis)
Significant terms of the agreement (in brief) special rights like right to appoint directors, first right to share subscription in case of issuance of shares, right to restrict any change in capital structure etc	NA
Whether, the said parties are related to promoter/promoter group/ group companies in anymanner. Ifyes,nature of relationship;	No
Whether the transaction would fall within related party transactions? If yes, whether the same is done at “arm’s length”;	No. The transaction does not constitute a related party transaction.
In case of issuance of shares to the parties, details of issue price, class of shares issued;	Huwel Lifesciences Private Limited will issue 9,965 equity shares in each tranche, aggregating to 19,930 equity shares, at a price of INR 7,760per share.
Any other disclosures related to such agreements, viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements,etc.;	NA
In case of termination or amendment of agreement, listed entity shall disclose additional details to the stock exchange(s): a) name of parties to the agreement; b) nature of the agreement; c) date of execution of the agreement; d) details of amendment and impact thereof or reasons of termination and impact thereof.	NA